VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
| Date | Status | Outer | Rating | Price |
|---|---|---|---|---|
| Apr-08-25 | Initiated | H.C. Wainwright | Buy | $2.50 |
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold | |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight | $8 → $7 |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight | $8 |
| May-16-18 | Initiated | Maxim Group | Buy | $6 |
| May-14-18 | Reiterated | The Benchmark Company | Buy | $7 → $5 |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy | $12 → $10 |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy | $12 |